about
Rifampicin producing neurological symptoms in a case of mid borderline (BB) leprosyAn epidemiological study on Mycobacterium leprae infection and prevalence of leprosy in endemic villages by molecular biological technique.Mycobacterium leprae DNA in daily using water as a possible source of leprosy infection.M. leprae recombinant antigens important for T-cell reactivity.Leprosy trend in Agra: observations from data collected from a hospital and field.Data utilization and analytical skills among NLEP managers. National Leprosy Elimination Programme.Cardiovascular dysautonomia in patients with lepromatous leprosy.Bacteriological study of pus isolates from neuropathic plantar ulcers associated with acute inflammatory phase.Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.Knowledge and practice of eye-care among leprosy patients.Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?Thrombocytopenic purpura with blood blisters on once a month rifampicin.Impact of integration on the profile of newly diagnosed leprosy patients attending a referral hospital in South India.Molecular techniques for leprosy: present applications and future perspectives.The absence of a catalase function in Mycobacterium leprae.Recombinant proteins from Mycobacterium leprae: current status.Use of polymerase chain reaction (PCR) in leprosy research.Recombinant antigen: current situation and future.Detection of drug-resistant Mycobacterium leprae using molecular methods.Bone changes in leprosy patients with disabilities/deformities (a clinico-radiological correlation).Techniques for covering soft tissue defects resulting from plantar ulcers in leprosy: Part I--General considerations and summary of results.Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy.Drug resistance in leprosy: lessons from past and future perspective.Immunotherapy and immunoprophylaxis of leprosy.Remaining challenges towards the elimination of leprosy. Leprosy Elimination Project World Health Organization.Detecting peripheral nerve damage in the field: our tools in 2000 and beyond.Leprosy control, elimination and eradication.Current views on reactions in leprosy.Systemic involvement in leprosy and its significance.Developments in experimental leprosy.Cytokine patterns using molecular tools.Prospects for chemotherapy of leprosy.Clinical leprosy through the last seventy-five years.Disability and rehabilitation in leprosy: issues and challenges.Current understanding of leprosy as a peripheral nerve disorder: significance of involvement of peripheral nerve in leprosy.Therapeutic prospects for paucibacillary leprosy.Recent advances in the microbiology of leprosy.Immunopathology of leprosy--current status.Current understanding of disability prevention.Surgical correction of deformities and disabilities in leprosy patients.
P1433
Q28319638-89AC888C-ABBA-4D3F-B274-E87FECFC1208Q30752305-417B1DA8-8099-4C94-84FB-8B334A20E615Q30752458-9F16AAC3-6543-4151-BB2E-F6804B08A067Q30752478-503162F6-40C6-4BDB-A719-CBA0F4ED4C67Q31056398-950FE7FB-1920-4E25-ACB7-94065C2F2408Q32114849-4CCFE7A5-C91B-43B9-8D7F-9ACD94FC9B06Q33162654-8CF5E1C1-8074-4FA4-A643-B175444CE557Q33181722-6BF24F5E-1190-49A0-974B-A6203CBB4B43Q33186305-27ABAB38-1AD1-488C-989B-F86D3D7EED98Q33186787-FF61D3F5-E17E-4F4A-BC50-6C3BD9039B93Q33214113-944DD75D-A333-4E86-B457-79E804F7531FQ33498239-8528BCBB-997A-415D-B7D4-F22656CF3A63Q33589961-683A6036-847D-40A3-9B7A-A6288DFF70EAQ33706466-893FA872-3B84-431E-9435-169A7AE571FBQ33706471-7F5E0FC9-B900-4DDF-A967-522E446C2AE0Q33706477-02C61CC6-BEFD-4D73-B544-B57D7181DA7BQ33706482-587A9733-FE31-40EB-A1A7-38EC71F42207Q33706487-910D0124-AA35-4566-B702-78101D26E417Q33706497-EF005A50-8063-4601-8D05-8016E77716E8Q33743931-04CACAD8-16D1-4785-A53F-6440F09561BBQ33811718-170EE21E-5ED2-4D7C-A46B-71367686DB11Q33854597-AD57968A-9F15-462C-9D56-7F88BC68BA5EQ33915076-033D87E9-60F2-46CC-8D31-E07E84D5317FQ33997527-8DDB3FB8-D81B-43D5-89CB-C61D5F57AFC9Q33997534-CBF0FDC4-3C4D-459D-BF3F-1F4D570A0974Q33997542-EAC3203D-F43D-49E9-816E-327B0927F7A2Q33997547-535293CC-03AF-429E-BD0D-39BC5A66E442Q33997554-C904BF0E-17A7-4C28-9001-34F6687882D5Q33997560-4338CD2D-3F24-4F96-94EB-9C40571AF350Q33997566-EAA6B55B-B417-4140-B867-A0B0F028E955Q34047879-ED8E1516-4988-4EA7-9D70-9D29D3E2601AQ34047886-B6FF8E7C-C6A0-4DC5-BABB-113CEE01AE1FQ34047893-AC468C83-7BEC-47F7-8302-515EC47D6BABQ34097815-691DDC76-29E2-4CBC-A694-3ECD540AAEF3Q34097820-DDC6E33C-898C-4D71-AD7F-AD2A5BFDC43CQ34097826-BDECDB9C-82C6-4909-A201-C43552F22467Q34097833-C38FA9C2-1B72-43EE-8FCD-024EAD2DD345Q34097839-2464F77B-B3F4-48A0-B6CD-5653CF012029Q34097844-2BA82112-E754-4076-BE9D-18732AE84AB9Q34097851-3D5DB785-D434-4069-97A4-97BE840178EF
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Indian journal of leprosy
@ast
Indian journal of leprosy
@en
Indian journal of leprosy
@es
Indian journal of leprosy
@it
Indian journal of leprosy
@nl
type
label
Indian journal of leprosy
@ast
Indian journal of leprosy
@en
Indian journal of leprosy
@es
Indian journal of leprosy
@it
Indian journal of leprosy
@nl
altLabel
Indian J Lepr
@en
prefLabel
Indian journal of leprosy
@ast
Indian journal of leprosy
@en
Indian journal of leprosy
@es
Indian journal of leprosy
@it
Indian journal of leprosy
@nl
P1055
P1156
P1476
Indian journal of leprosy
@en